Fig. 4From: Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approachOverall survival of sequential treatment in the a whole and b matched populationsBack to article page